Sigyn Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $99.4K | $95 |
| FY2015 | — | $-82.0K | $638.8K |
| FY2016 | — | $-691.8K | $149.6K |
| FY2017 | — | $-2.1M | $9.6K |
| FY2018 | — | $-3.7M | $7.5K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $99.4K | $95 |
| FY2015 | — | $-82.0K | $638.8K |
| FY2016 | — | $-691.8K | $149.6K |
| FY2017 | — | $-2.1M | $9.6K |
| FY2018 | — | $-3.7M | $7.5K |